Antisense Oligonucleotides for Duchenne Muscular Dystrophy: Why No Neurologist Should Skip This

JAMA Neurol. 2016 Mar;73(3):259-60. doi: 10.1001/jamaneurol.2015.4011.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Muscular Dystrophy, Duchenne / drug therapy*
  • Oligonucleotides, Antisense / therapeutic use*

Substances

  • Oligonucleotides, Antisense